SAS#19 Flashcards
Lower serum levels of cholesterol and various lipids. They are also called as lipid-lowering agents
ANTIHYPERLIPIDEMIC DRUGS
C a d is the leading cause of death worldwide and its incidence is highly and people with
HYPERLIPIDEMIA
These drugs are used to normalize high serum levels of cholesterol
BILE ACID SEQUESTRANTS
Exert their effect in the intestine by binding into bile acids which contain a high level of cholesterol
BILE ACID SEQUESTRANTS
Is also used to treat pruritus associated with partial biliary obstruction
CHOLESTYRAMINE
this drug group increases the cell absorption of ldl by blocking the enzyme regulating the rate-limiting step in the synthesis of cholesterol
HMG CoA REDUCTASE INHIBITORS
Block the completion of cholesterol synthesis in the body
HMG Coa reductase inhibitors
Are indicated for patients with documented c a d to slow progression of the disease
PRAVASTATIN
LOVASTATIN
SIMVASTATIN
Pravastatin lovastatin and simvastatin, together with this three agents _____ is used as prophylaxis for first myocardial infarction attack for patients with multiple risk factors for c a d
ATORVASTATIN
Is the drug of choice for patients who have multiple risk factor or have already develop c a d
HMG-COA REDUCTASE INHIBITOR
This class is well tolerated and is less expensive compared to other classes with the same therapeutic effect
HMG-
Increased serum levels and resultant of hmg-coa reductase inhibitors
DIGOXIN
WARFARIN
Atorvastatin can be given at
ANY HOUR OF THE DAY
administered drug at bedtime to maximize effectiveness of the drugs because pic of cholesterol synthesis is from midnight to 5:00 a.m.
HMG COA REDUCTASE INHIBITOR
Are one of the new class of drug approved to lower serum cholesterol levels
CHOLESTEROL ABSORPTION INHIBITOR
Acting on the brush border of intestine,_____block the absorption of dietary cholesterol
CHOLESTEROL ABSORPTION INHIBITOR
Increased toxicity of cholesterol absorption inhibitors
CYCLOSPORINE
Increased risk for development of cholelithiasis
FIBRATES
Altering the formation of platelet plug
ANTIPLATELET DRUG
Altering interfering the clotting cascade and thrombin formation
ANTICOAGULANT DRUGS
Altering the stimulating of the plasmin system to break down the formed class
THROMBOLYTIC AGENTS
DisOrders that directly affect coagulation process
THROMBOEMBOLIC DISORDERS
HEMORRHAGIC DISORDERS
Which involve overproduction of clots
THROMBOEMBOLIC DISORDERS
Which is characterized by ineffective clotting process leading to excessive bleeding
HEMORRHAGIC DISORDERS